Abbott Labs Posts Higher 4Q Sales, Despite Soft Demand

Jan 24, 2024  · The Abbott Park, Ill.-based healthcare products company reported a profit of $1.59 billion, or 91 cents a share, up from $1.03 billion, or 59 cents a share, in the same period a …


Install CouponFollow Chrome Extension   CouponFollow Extension

$1.59
OFF

Abbott Labs Posts Higher 4Q Sales, Despite Soft Demand

1 week from now

Jan 24, 2024  · The Abbott Park, Ill.-based healthcare products company reported a profit of $1.59 billion, or 91 cents a share, up from $1.03 billion, or 59 cents a share, in the same period a …

morningstar.com

0%
OFF

Abbott Reports Fourth-Quarter And Full-Year 2023 ... - Abbott …

1 week from now

Jan 24, 2024  · Abbott projects full-year 2024 organic sales growth, excluding COVID-19 testing-related sales, to be in the range of 8.0% to 10.0% 2. In 2023, Abbott continued to recapture …

mediaroom.com

$10.24
OFF

Abbott Laboratories Surpasses Q4 Sales Expectations, Despite Dip …

1 week from now

Abbott Laboratories (NYSE:ABT) posted higher sales of $10.24 billion in the fourth quarter, despite continued soft demand for the company’s Covid-19 testing equipment, beating the …

msn.com

2%
OFF

Abbott Labs' Fourth-quarter Sales Top Estimates Amid Strong …

1 week from now

Jan 24, 2024  · Abbott Laboratories' stock (ABT) fell 2% premarket on Wednesday after the healthcare-products company reported fourth-quarter sales that topped expectations amid …

morningstar.com

36%
OFF

The Story Behind Abbott's Strong Fourth Quarter

1 week from now

Jan 26, 2022  · Sales of FreeStyle Libre systems were $1 billion, which translates to an increase of 36% organic (35.4% reported). Solid Diagnostics sales — up 3.3% organic (2.9% reported) — …

abbott.com

$1.59
OFF

Abbott Labs' Q4 Sales Top Estimates Amid Strong Medical-device …

1 week from now

The company reported fourth-quarter net income of $1.59 billion, or 91 cents per share, versus $1.03 billion, or 59 cents per share, in the year-earlier period. Adjusted per-share earnings …

marketwatch.com

$3.65
OFF

Abbott Q4 Earnings: Exceptional Growth | Abbott Newsroom

1 week from now

Jan 27, 2021  · This momentum was key to Abbott achieving full-year 2020 adjusted diluted earnings-per-share (EPS) from continuing operations of $3.65, which is the upper-end of the …

abbott.com

$2
OFF

Abbott Labs: We’ve Shipped 1.4 Billion Covid Tests Since ... - Forbes

1 week from now

Jan 26, 2022  · Abbott’s global Covid-19 testing sales hit $2.3 billion in the fourth quarter and the bulk of that, or $2.1 billion, came from Abbott’s family of rapid tests: BinaxNOW, Panbio and ID …

forbes.com

$4.64
OFF

Abbott Laboratories Raises Its Outlook On Strong Medical Device …

1 week from now

Oct 16, 2024  · Abbott said it expects full-year adjusted EPS in the range of $4.64 to $4.70, compared to the $4.61 to $4.71 range it projected when it announced its second-quarter …

investopedia.com

4%
OFF

Abbott Labs Has Shipped 1 Billion Covid Tests Since Pandemic …

1 week from now

Oct 20, 2021  · Abbott’s third-quarter sales rose 23.4% to $10.9 billion and included $1.9 billion in revenue from global Covid-19 related testing sales, the company said. Net income jumped …

forbes.com

FAQs about Abbott Labs Posts Higher 4Q Sales, Despite Soft Demand Coupon?

Why did Abbott Laboratories stock fall 2% premarket?

Want to see it on more articles? Abbott Laboratories’ stock ABT, -2.83% fell 2% premarket on Wednesday after the healthcare-products company reported fourth-quarter sales that topped expectations amid strength in its medical-device and nutrition segments, even as COVID-test sales continued to plunge. ...

What will Abbott's organic sales look like in 2024?

Abbott projects full-year 2024 organic sales growth, excluding COVID-19 testing-related sales, to be in the range of 8.0% to 10.0% 2. In 2023, Abbott continued to recapture market share in the U.S. infant formula market. The company has now reclaimed its previous market-leading position, as measured on a volume basis. ...

How did Abbott's Diagnostics sales perform in the fourth quarter?

“Worldwide diagnostics sales increased 2.9 percent on a reported basis in the fourth quarter and increased 3.3 percent on an organic basis,” Abbott said in its fourth quarter and full year 2021 earnings report. ...

How did Abbott perform in Q4 2023?

ABBOTT PARK, Ill., Jan. 24, 2024 / PRNewswire / -- Abbott today announced financial results for the fourth quarter ended Dec. 31, 2023. Fourth-quarter sales increased 1.5 percent on a reported basis, 2.1 percent on an organic basis, and 11.0 percent on an organic basis, excluding COVID-19 testing-related sales 1. ...

What will Abbott's earnings look like in 2024?

For the full year 2024, Abbott is expecting adjusted earnings per share in the range of $4.50 to $4.70, and organic sales growth, excluding COVID testing, in the range of 8% to 10%, the company said Wednesday. Abbott shares have gained 1.3% in the past 12 months, while the S&P 500 SPX is up 21%. ...

What drives Abbott's growth in diagnostics?

Tremendous growth in Diagnostics, 108.9% organic (111.1% reported), was driven by continued global demand for Abbott's portfolio of nearly a dozen rapid and lab-based COVID-19 tests, which can be used in a variety of settings. The latest of these tests is Abbott’s BinaxNOW rapid test for at-home use with a virtually guided service. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension